Safety of omalizumab administration in chronic spontaneous urticaria
during COVID-19 infection: a case report.
- Marisa Paulino,
- Célia Costa,
- Elisa Pedro
Célia Costa
Centro Hospitalar Universitario Lisboa Norte EPE
Author ProfileElisa Pedro
Centro Hospitalar Universitario Lisboa Norte EPE
Author Profile
